Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHA:688179)
China · Delayed Price · Currency is CNY 22.20
+1.62 (7.87%)
At close: May 7, 2026
SHA:688179 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 727.02 | 686.46 | 524.39 | 396.72 | 371.02 | 281.25 |
Other Revenue | - | - | 9.17 | 6.16 | 7.08 | 6.41 |
| 727.02 | 686.46 | 533.56 | 402.88 | 378.1 | 287.66 | |
Revenue Growth (YoY) | 28.62% | 28.66% | 32.44% | 6.55% | 31.44% | 22.82% |
Cost of Revenue | 5.53 | - | 204.38 | 162.54 | 156.28 | 110.11 |
Gross Profit | 721.48 | 686.46 | 329.18 | 240.33 | 221.82 | 177.55 |
Selling, General & Admin | 14.44 | - | 132.56 | 96.08 | 83.96 | 61.35 |
Research & Development | 1.88 | - | 62.51 | 51.07 | 38.7 | 22.32 |
Other Operating Expenses | 533.03 | 532.13 | 4.49 | 0.78 | 3.22 | 1.52 |
Operating Expenses | 549.4 | 532.13 | 200.69 | 148.1 | 127.2 | 85.52 |
Operating Income | 172.08 | 154.33 | 128.49 | 92.23 | 94.63 | 92.03 |
Interest Expense | - | - | -7.29 | -6.69 | -4.67 | -0.41 |
Interest & Investment Income | 1.84 | - | 5.87 | 6.89 | 8.28 | 10.16 |
Currency Exchange Gain (Loss) | - | - | 0.01 | 0.11 | 0.4 | -0.11 |
Other Non Operating Income (Expenses) | -3.88 | 0.11 | -1.16 | -0.57 | -0.69 | -0.4 |
EBT Excluding Unusual Items | 170.03 | 154.44 | 125.92 | 91.97 | 97.95 | 101.27 |
Gain (Loss) on Sale of Investments | 0.2 | - | 0.55 | 1.46 | 1.3 | 0.35 |
Gain (Loss) on Sale of Assets | 0.15 | - | -0.1 | -0.13 | 0.19 | -1.47 |
Asset Writedown | -7.18 | - | - | - | - | - |
Other Unusual Items | - | - | 1.27 | 1.6 | 6.24 | 1.56 |
Pretax Income | 163.2 | 154.44 | 127.63 | 94.91 | 105.67 | 101.71 |
Income Tax Expense | 52.06 | 50.99 | 11.91 | 9.08 | 12.9 | 12.35 |
Earnings From Continuing Operations | 111.14 | 103.45 | 115.72 | 85.83 | 92.77 | 89.36 |
Minority Interest in Earnings | -2.78 | - | -16.96 | - | - | - |
Net Income | 108.36 | 103.45 | 98.76 | 85.83 | 92.77 | 89.36 |
Net Income to Common | 108.36 | 103.45 | 98.76 | 85.83 | 92.77 | 89.36 |
Net Income Growth | 2.38% | 4.75% | 15.07% | -7.48% | 3.82% | 20.06% |
Shares Outstanding (Basic) | 328 | 334 | 329 | 294 | 339 | 331 |
Shares Outstanding (Diluted) | 338 | 334 | 339 | 303 | 346 | 331 |
Shares Change (YoY) | -0.34% | -1.44% | 11.75% | -12.51% | 4.75% | 25.43% |
EPS (Basic) | 0.33 | 0.31 | 0.30 | 0.29 | 0.27 | 0.27 |
EPS (Diluted) | 0.32 | 0.31 | 0.29 | 0.28 | 0.27 | 0.27 |
EPS Growth | 2.73% | 6.27% | 2.96% | 5.75% | -0.89% | -4.29% |
Free Cash Flow | - | - | 115.99 | 10.11 | -105.23 | -98.38 |
Free Cash Flow Per Share | - | - | 0.34 | 0.03 | -0.30 | -0.30 |
Dividend Per Share | - | - | 0.167 | 0.179 | 0.106 | 0.121 |
Dividend Growth | - | - | -6.66% | 68.02% | -12.51% | -19.96% |
Gross Margin | 99.24% | 100.00% | 61.70% | 59.65% | 58.67% | 61.72% |
Operating Margin | 23.67% | 22.48% | 24.08% | 22.89% | 25.03% | 31.99% |
Profit Margin | 14.90% | 15.07% | 18.51% | 21.30% | 24.54% | 31.06% |
Free Cash Flow Margin | - | - | 21.74% | 2.51% | -27.83% | -34.20% |
EBITDA | - | 178.52 | 152.67 | 109.47 | 107.33 | 101.74 |
EBITDA Margin | - | 26.01% | 28.61% | 27.17% | 28.38% | 35.37% |
D&A For EBITDA | - | 24.19 | 24.19 | 17.24 | 12.7 | 9.72 |
EBIT | 172.08 | 154.33 | 128.49 | 92.23 | 94.63 | 92.03 |
EBIT Margin | 23.67% | 22.48% | 24.08% | 22.89% | 25.03% | 31.99% |
Effective Tax Rate | 31.90% | 33.02% | 9.33% | 9.56% | 12.21% | 12.14% |
Revenue as Reported | 40.55 | - | 533.56 | 402.88 | 378.1 | 287.66 |
Advertising Expenses | - | - | 11.44 | 5.46 | 3.9 | 3.34 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.